{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:07:26Z","timestamp":1789099646183,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007190","name":"Unilever","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["P42 ES027704"],"award-info":[{"award-number":["P42 ES027704"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019191","name":"College of Agriculture and Life Sciences, Texas A and M University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Toxicology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cotox.2026.100601","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:38:28Z","timestamp":1782200308000},"page":"100601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Next-generation risk assessment in cosmetic safety: Moving from the frameworks and case studies to wide Adoption"],"prefix":"10.1016","volume":"47","author":[{"given":"Ivan","family":"Rusyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihsueh A.","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Dent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cotox.2026.100601_bib1","series-title":"Roadmap to reducing animal testing in preclinical safety studies","year":"2025"},{"key":"10.1016\/j.cotox.2026.100601_bib2","series-title":"Cosmetics","year":"2026"},{"key":"10.1016\/j.cotox.2026.100601_bib3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00204-011-0693-2","article-title":"Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010","volume":"85","author":"Adler","year":"2011","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.cotox.2026.100601_bib4","article-title":"The SCCS notes of guidance for the testing of cosmetic ingredients and their safety evaluation, 11th revision, 30-31 march 2021, SCCS\/1628\/21","volume":"127","year":"2021","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.cotox.2026.100601_sref5","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.105026","article-title":"Paving the way for application of next generation risk assessment to safety decision-making for cosmetic ingredients","volume":"125","author":"Dent","year":"2021","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.cotox.2026.100601_sref6","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1289\/EHP233","article-title":"The next generation of risk assessment multi-year study-highlights of findings, applications to risk assessment, and future directions","volume":"124","author":"Cote","year":"2016","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.cotox.2026.100601_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2025.105818","article-title":"Report of the european commission workshop on \"the roadmap towards phasing out animal testing for chemical safety assessments\", Brussels, 11-12 December 2023","volume":"161","author":"Cronin","year":"2025","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.cotox.2026.100601_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.comtox.2021.100175","article-title":"COSMOS next generation - a public knowledge base leveraging chemical and biological data to support the regulatory assessment of chemicals","volume":"19","author":"Yang","year":"2021","journal-title":"Comput Toxicol"},{"key":"10.1016\/j.cotox.2026.100601_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/toxsci\/kfad134","article-title":"Ten years of using key characteristics of human carcinogens to organize and evaluate mechanistic evidence in IARC monographs on the identification of carcinogenic hazards to humans: patterns and associations","volume":"198","author":"Rusyn","year":"2024","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.cotox.2026.100601_bib10","first-page":"359","article-title":"Ready for regulatory use: NAMs and NGRA for chemical safety assurance","volume":"39","author":"Carmichael","year":"2022","journal-title":"ALTEX"},{"key":"10.1016\/j.cotox.2026.100601_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.105094","article-title":"A 10-step framework for use of read-across (RAX) in next generation risk assessment (NGRA) for cosmetics safety assessment","volume":"129","author":"Alexander-White","year":"2022","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.cotox.2026.100601_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2025.105863","article-title":"Countdown to 2027 - maximising use of NAMs in food safety assessment: closing the gap for regulatory assessments in Europe","volume":"162","author":"Wood","year":"2025","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.cotox.2026.100601_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2025.154211","article-title":"Next generation risk assessment and new approach methodologies for safe and sustainable by design chemicals and materials: perspectives and challenges for occupational health","volume":"517","author":"Leso","year":"2025","journal-title":"Toxicology"},{"key":"10.1016\/j.cotox.2026.100601_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2024.114998","article-title":"Predicting points of departure and potency categories for fragrance ingredients by integrating OECD in vitro models","volume":"193","author":"Lee","year":"2024","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.cotox.2026.100601_bib15","first-page":"439","article-title":"Applying a next generation risk assessment framework for skin sensitisation to inconsistent new approach methodology information","volume":"40","author":"Gilmour","year":"2023","journal-title":"ALTEX"},{"key":"10.1016\/j.cotox.2026.100601_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.crtox.2024.100205","article-title":"The skin allergy risk assessment-integrated chemical environment (SARA-ICE) defined approach to derive points of departure for skin sensitization","volume":"8","author":"Reinke","year":"2025","journal-title":"Curr Res Toxicol"},{"key":"10.1016\/j.cotox.2026.100601_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/toxsci\/kfae159","article-title":"Advancing systemic toxicity risk assessment: evaluation of a NAM-based toolbox approach","volume":"204","author":"Cable","year":"2025","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.cotox.2026.100601_sref18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/toxsci\/kfac068","article-title":"Are non-animal systemic safety assessments protective? A toolbox and workflow","volume":"189","author":"Middleton","year":"2022","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.cotox.2026.100601_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2024.153826","article-title":"A workflow to practically apply true dose considerations to in vitro testing for next generation risk assessment","volume":"505","author":"Nicol","year":"2024","journal-title":"Toxicology"},{"key":"10.1016\/j.cotox.2026.100601_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.namjnl.2025.100056","article-title":"Sensitivity analysis of the inputs for bioactivity-exposure ratio calculations in a NAM-based systemic safety toolbox","volume":"1","author":"Lin","year":"2025","journal-title":"NAM J"},{"key":"10.1016\/j.cotox.2026.100601_bib21","first-page":"158","article-title":"An Alternative Safety Profiling Algorithm (ASPA) to transform next generation risk assessment into a structured and transparent process","volume":"43","author":"Leist","year":"2026","journal-title":"ALTEX"},{"key":"10.1016\/j.cotox.2026.100601_bib22","first-page":"213","article-title":"Qualitative and quantitative concentration-response modelling of gene co-expression networks to unlock hepatotoxic mechanisms for next generation chemical safety assessment","volume":"41","author":"Kunnen","year":"2024","journal-title":"ALTEX"},{"key":"10.1016\/j.cotox.2026.100601_bib23","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00204-023-03480-w","article-title":"Next generation risk assessment of human exposure to estrogens using safe comparator compound values based on in vitro bioactivity assays","volume":"97","author":"van Tongeren","year":"2023","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.cotox.2026.100601_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2021.105132","article-title":"Next generation risk assessment of human exposure to anti-androgens using newly defined comparator compound values","volume":"73","author":"van Tongeren","year":"2021","journal-title":"Toxicol Vitro"},{"key":"10.1016\/j.cotox.2026.100601_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2025.1426132","article-title":"Evaluation of a non-animal toolbox informed by adverse outcome pathways for human inhalation safety","volume":"7","author":"de \u00c1vila","year":"2025","journal-title":"Front Toxicol"},{"key":"10.1016\/j.cotox.2026.100601_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2025.1602065","article-title":"An advancement in developmental and reproductive toxicity (DART) risk assessment: evaluation of a bioactivity and exposure-based NAM toolbox","volume":"7","author":"Mueller","year":"2025","journal-title":"Front Toxicol"},{"key":"10.1016\/j.cotox.2026.100601_bib27","doi-asserted-by":"crossref","first-page":"kfag038","DOI":"10.1093\/toxsci\/kfag038","article-title":"Quantitative estimates of inter-individual variability for new approach methodologies-based systemic safety toolbox using a population-based human in vitro model","volume":"209","author":"Alshammari","year":"2026","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.cotox.2026.100601_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2019.104746","article-title":"Application of physiologically based kinetic (PBK) modelling in the next generation risk assessment of dermally applied consumer products","volume":"63","author":"Moxon","year":"2020","journal-title":"Toxicol Vitro"},{"key":"10.1016\/j.cotox.2026.100601_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1421650","article-title":"Development and validation of PBPK models for genistein and daidzein for use in a next-generation risk assessment","volume":"15","author":"Najjar","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cotox.2026.100601_bib30","first-page":"113","article-title":"Building confidence in PBK model predictions in the absence of human kinetic data: Benzophenone-4 case study","volume":"43","author":"Punt","year":"2026","journal-title":"ALTEX"},{"key":"10.1016\/j.cotox.2026.100601_bib31","first-page":"511","article-title":"Making safety decisions for a sunscreen active ingredient using next-generation risk assessment: Benzophenone-4 case study","volume":"42","author":"Baltazar","year":"2025","journal-title":"ALTEX"},{"key":"10.1016\/j.cotox.2026.100601_bib32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/toxics13020110","article-title":"Next generation risk assessment to address disease-related Vulnerability-A proof of concept for the sunscreen octocrylene","volume":"13","author":"Fern\u00e1ndez-Mart\u00edn","year":"2025","journal-title":"Toxics"},{"key":"10.1016\/j.cotox.2026.100601_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.namjnl.2025.100068","article-title":"Investigations into the biological activity of avobenzone as part of a next generation risk assessment","volume":"2","author":"Shan","year":"2026","journal-title":"NAM J"},{"key":"10.1016\/j.cotox.2026.100601_bib34","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/toxsci\/kfaa048","article-title":"A next-generation risk assessment case study for coumarin in cosmetic products","volume":"176","author":"Baltazar","year":"2020","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.cotox.2026.100601_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2024.153835","article-title":"Next generation risk assessment for occupational chemical safety - a real world example with sodium-2-hydroxyethane sulfonate","volume":"506","author":"Wood","year":"2024","journal-title":"Toxicology"},{"key":"10.1016\/j.cotox.2026.100601_bib36","series-title":"Case study on use of an integrated approach for testing and assessment (IATA) for systemic toxicity of phenoxyethanol when included at 1% in a body lotion","year":"2021"},{"key":"10.1016\/j.cotox.2026.100601_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1345992","article-title":"Next generation risk assessment: an ab initio case study to assess the systemic safety of the cosmetic ingredient, benzyl salicylate, after dermal exposure","volume":"15","author":"Ebmeyer","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cotox.2026.100601_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.104931","article-title":"New framework for a non-animal approach adequately assures the safety of cosmetic ingredients - a case study on caffeine","volume":"123","author":"Bury","year":"2021","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.cotox.2026.100601_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2025.105961","article-title":"Safe usage levels of aqueous Hippophae rhamnoides fruit extract in cosmetics estimated by threshold of toxicological concern, point of departure, and history of safe consumption","volume":"164","author":"Cho","year":"2026","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.cotox.2026.100601_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2019.103296","article-title":"Integrating in vitro testing and physiologically-based pharmacokinetic (PBPK) modelling for chemical liver toxicity assessment-A case study of troglitazone","volume":"74","author":"Yu","year":"2020","journal-title":"Environ Toxicol Pharmacol"},{"key":"10.1016\/j.cotox.2026.100601_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2025.105794","article-title":"Next generation risk assessment of hair dye HC yellow no. 13: ensuring protection from liver steatogenic effects","volume":"159","author":"Sepehri","year":"2025","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.cotox.2026.100601_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2022.105161","article-title":"Read-across and new approach methodologies applied in a 10-step framework for cosmetics safety assessment - a case study with parabens","volume":"132","author":"Ouedraogo","year":"2022","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.cotox.2026.100601_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2022.881235","article-title":"Next generation risk assessment of the anti-androgen flutamide including the contribution of its active metabolite hydroxyflutamide","volume":"4","author":"van Tongeren","year":"2022","journal-title":"Front Toxicol"},{"key":"10.1016\/j.cotox.2026.100601_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2021.105171","article-title":"Next generation risk assessment (NGRA): bridging in vitro points-of-departure to human safety assessment using physiologically-based kinetic (PBK) modelling - a case study of doxorubicin with dose metrics considerations","volume":"74","author":"Li","year":"2021","journal-title":"Toxicol Vitro"},{"key":"10.1016\/j.cotox.2026.100601_sref45","series-title":"Building confidence in new evidence streams for human health risk assessment: lessons learned from laboratory mammalian toxicity tests","year":"2023"},{"key":"10.1016\/j.cotox.2026.100601_bib46","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1007\/s00204-025-04168-z","article-title":"Exploring experiences of the regulatory toxicology system: system-level promoters and inhibitors of new approach methodologies","volume":"99","author":"Bearth","year":"2025","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.cotox.2026.100601_bib47","first-page":"127","article-title":"What does \"success\" look like in compliance check decisions by the european chemicals agency? The curious cases of accepted read-across adaptations","volume":"43","author":"Roe","year":"2026","journal-title":"ALTEX"},{"key":"10.1016\/j.cotox.2026.100601_bib48","first-page":"22","article-title":"A systematic analysis of read-across adaptations in testing proposal evaluations by the european chemicals agency","volume":"42","author":"Roe","year":"2025","journal-title":"ALTEX"},{"key":"10.1016\/j.cotox.2026.100601_bib49","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/toxsci\/kfaf058","article-title":"ToxPoint: of hammers and nails-understanding academic challenges with \"context of use\" and \"fit for purpose\"","volume":"207","author":"Rusyn","year":"2025","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.cotox.2026.100601_sref50","series-title":"Toxicity testing in the 21st century: a vision and a strategy","year":"2007"}],"container-title":["Current Opinion in Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246820202600032X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246820202600032X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:31:50Z","timestamp":1789097510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246820202600032X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":50,"alternative-id":["S246820202600032X"],"URL":"https:\/\/doi.org\/10.1016\/j.cotox.2026.100601","relation":{},"ISSN":["2468-2020"],"issn-type":[{"value":"2468-2020","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Next-generation risk assessment in cosmetic safety: Moving from the frameworks and case studies to wide Adoption","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cotox.2026.100601","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100601"}}